Progressive multifocal leukoencephalopathy in a patient with novel mutation in the RAC2 gene: a case report.
Common variable immunodeficiency
Progressive multifocal leukoencephalopathy
RAC2 mutation
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
11 Jun 2022
11 Jun 2022
Historique:
received:
05
05
2021
accepted:
17
02
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
15
6
2022
Statut:
epublish
Résumé
Progressive multifocal leukoencephalopathy is a rare demyelinating disease that is often secondary to lytic destruction of oligodendrocytes and, to a lesser extent, to astrocytes' response to human neurotrophic John Cunningham polyomavirus. Any underlying congenital disorder of primary or secondary immunodeficiency may predispose to virus infection and possible invasion of the brain. We present the first reported case of progressive multifocal leukoencephalopathy due to a mutation in the RAC2 gene. We describe the case of a 34-year-old Iranian man with recurrent infections from the age of 2 years, along with other disorders such as nephritic syndrome, factor XI deficiency, and hypogammaglobulinemia. He was treated regularly with intravenous immunoglobulin from the age of 10 years with a diagnosis of common variable immune deficiency. Genetic testing confirmed a novel homozygous mutation in the RAC2 gene in the patient. Owing to the onset of neurological symptoms a few months ago, the patient was completely avaluated, which confirmed the diagnosis of PML. Despite all efforts, the patient died shortly after progression of neurological symptoms. According to previous studies, progressive multifocal leukoencephalopathy has been associated with 26 cases of primary immunodeficiency. Our patient presents a new case of primary immunodeficiency with progressive multifocal leukoencephalopathy. Accurate examination of these cases can help us to gain insight into the immune response to John Cunningham virus and better treat this potentially deadly disease.
Sections du résumé
BACKGROUND
BACKGROUND
Progressive multifocal leukoencephalopathy is a rare demyelinating disease that is often secondary to lytic destruction of oligodendrocytes and, to a lesser extent, to astrocytes' response to human neurotrophic John Cunningham polyomavirus. Any underlying congenital disorder of primary or secondary immunodeficiency may predispose to virus infection and possible invasion of the brain. We present the first reported case of progressive multifocal leukoencephalopathy due to a mutation in the RAC2 gene.
CASE PRESENTATION
METHODS
We describe the case of a 34-year-old Iranian man with recurrent infections from the age of 2 years, along with other disorders such as nephritic syndrome, factor XI deficiency, and hypogammaglobulinemia. He was treated regularly with intravenous immunoglobulin from the age of 10 years with a diagnosis of common variable immune deficiency. Genetic testing confirmed a novel homozygous mutation in the RAC2 gene in the patient. Owing to the onset of neurological symptoms a few months ago, the patient was completely avaluated, which confirmed the diagnosis of PML. Despite all efforts, the patient died shortly after progression of neurological symptoms.
CONCLUSIONS
CONCLUSIONS
According to previous studies, progressive multifocal leukoencephalopathy has been associated with 26 cases of primary immunodeficiency. Our patient presents a new case of primary immunodeficiency with progressive multifocal leukoencephalopathy. Accurate examination of these cases can help us to gain insight into the immune response to John Cunningham virus and better treat this potentially deadly disease.
Identifiants
pubmed: 35689244
doi: 10.1186/s13256-022-03333-7
pii: 10.1186/s13256-022-03333-7
pmc: PMC9188039
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
235Informations de copyright
© 2022. The Author(s).
Références
J Clin Immunol. 2015 Jan;35(1):92-6
pubmed: 25388448
PLoS One. 2015 Jun 10;10(6):e0129694
pubmed: 26061652
Exp Cell Res. 2013 Sep 10;319(15):2375-83
pubmed: 23850828
Virology. 1994 Jan;198(1):59-70
pubmed: 8259683
Lancet. 1959 Oct 10;2(7102):524-9
pubmed: 13808583
Neurology. 2013 Apr 9;80(15):1430-8
pubmed: 23568998
J Allergy Clin Immunol. 2015 May;135(5):1380-4.e1-5
pubmed: 25512081
Neuropediatrics. 2001 Oct;32(5):250-5
pubmed: 11748496
J Clin Immunol. 2019 Jan;39(1):55-64
pubmed: 30552536
Clin Infect Dis. 2016 Apr 15;62(8):986-94
pubmed: 26743090
Clin Dev Immunol. 2013;2013:839719
pubmed: 23690827
Brain. 1958 Mar;81(1):93-111
pubmed: 13523006